Health Care/Hospital
Everest Medicines Announces Commercial Launch and First Prescription for NEFECON® in Mainland China
SHANGHAI, May 14, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines and vaccines, today announced that NEFECON®, a delayed rel...
2024-05-14 21:41
560
IMG Shares 2024 Summer Travel Trends and Top Destinations
* IMG reviewed the travel itineraries of more than 23,000 of its members with upcoming travel plans betweenJune 1st and August 31st of 2024 to determine emerging travel trends this summer. INDIANAPOLIS, May 14, 2024 /PRNewswire/ -- IMG (International Medical Group), an award-winning global insu...
2024-05-14 21:00
522
HUB Organoids B.V. Awarded Frost & Sullivan's 2024 Technology Innovation Leadership Award for Transforming Drug Development with Highly Advanced Organoid Technology
HUB Organoids Holdings B.V. revolutionizes pre-clinical and clinical drug development through its cutting-edge organoid technology, enhancing its accuracy and efficiency. SAN ANTONIO, May 14, 2024 /PRNewswire/ -- Frost & Sullivan recently researched the organoids landscape and, based on its find...
2024-05-14 20:00
608
HealthTech Bioactives Partners with Abolis for Sustainable Production of High-Value Polyphenols
PARIS, May 14, 2024 /PRNewswire/ -- HealthTech Bioactives (HTBA) has chosen Abolis as their partner to develop strains to produce valuable polyphenols, addressing supply chain challenges and driving innovation in the industry. Founded in 2019, after 40 years' experience under different ownership,...
2024-05-14 20:00
546
Novosis Putty Sets the Stage for U.S. Market Success with Promising Clinical Results
SEOUL, South Korea, May 14, 2024 /PRNewswire/ -- CGBio, a leading medical device company, announced a significant clinical results demonstrating a 100% interbody fusion success rate at 52 weeks for its innovative bone substitutes, "Novosis" and "Excelos Inject," which have been published in the '...
2024-05-14 20:00
644
Pantai Hospital Kuala Lumpur Continues Legacy of Care with Community Health Screening for the Lembah Pantai Community
KUALA LUMPUR, Malaysia, May 14, 2024 /PRNewswire/ -- Pantai Hospital Kuala Lumpur, together with Premier Integrated Labs, Pantai Integrated Rehab, and Twin Tower Medical Centre, and with support from the Breast Cancer Welfare Association Malaysia and AstraZeneca, marked a milestone in their conti...
2024-05-14 19:41
723
Qomolangma Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Filing of Annual Report on Form 10-K
NEW YORK, May 14, 2024 /PRNewswire/ -- Qomolangma Acquisition Corp. (Nasdaq: QOMO) (the "Company") announced that it has received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has not yet filed its Form 10-K for the period endedDecember 31, 2...
2024-05-14 18:30
605
Xinhua Silk Road: China's Tasly releases white paper, large model on TCM digital intelligence
BEIJING, May 14, 2024 /PRNewswire/ -- China's TCM product developer Tasly
Pharmaceutical Group Co., Ltd. issued a white paper on digital intelligence of
traditional Chinese medicine (TCM) and launched a related large model at an
industrial conference onMay 9, 2024.
2024-05-14 17:07
654
Allozymes Raises $15 Million in Series A Funding, Poised to Revolutionize Industries with Enzymatic Solutions
SINGAPORE, May 14, 2024 /PRNewswire/ -- Allozymes, a leading innovator in enzyme discovery and engineering, today announced the closing of a$15 million Series A funding round led by Seventure Partners ofFrance and Xora Innovation of Singapore. This significant investment underscores the growing re...
2024-05-14 11:24
1249
VISTA Eye Specialist Celebrates Families and Vision with Vibrant Eye Carnival
PETALING JAYA, Malaysia, May 14, 2024 /PRNewswire/ -- VISTA Eye Specialist ('VISTA') is thrilled to announce its upcoming VISTA Parents' Day Eye Carnival ('Eye Carnival'), a celebration of family, wellness, and the gift of sight. This special event, held over two weekends, 24-26 May and 31 May -2...
2024-05-14 08:00
990
OrthAlign Launches Lantern® Handheld Technology for Total, Partial, and Revision Knee Arthroplasty in Japan.
IRVINE, Calif., May 14, 2024 /PRNewswire/ -- OrthAlign, Inc., a leading innovator in surgical technology, announces the launch of its flagship product, Lantern, inJapan. The launch will be driven by its longstanding commercial partner, who have represented OrthAlign in the market since 2013 and s...
2024-05-14 08:00
952
Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive Clinical Evidence from Multiple Phase 2 Studies
DURHAM, N.C. and BEIJING, May 14, 2024 /PRNewswire/ -- Brii Biosciences Limited
2024-05-14 07:27
1024
Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer
SHANGHAI, May 13, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced the progress of the clinical study of its novel Nectin-4-targeting ADC (R&D code: 9MW2821) for triple-negative breast cancer. Based on 9MW2821's curren...
2024-05-13 22:00
1261
ObeEnd - Pioneering Drug-Free Weight Management Wristband
VANCOUVER, BC, May 13, 2024 /PRNewswire/ -- WAT Medical, a leader in innovative healthcare solutions, announces the development of ObeEnd, the world's first weight management wristband backed by clinical evidence showcasing its efficacy in reducing dietary intake. Findings from this groundbreakin...
2024-05-13 21:00
850
BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000
SHENZHEN, China, May 13, 2024 /PRNewswire/ -- On May 10, 2024, the BGI-Heilongjiang Omics Health Axis Intelligent Laboratory (BGI-HL OHA Intelligent Laboratory) was inaugurated inHarbin, Heilongjiang province, China, marking a significant advance in the province's efforts to address public healt...
2024-05-13 13:34
1282
SCG Cell Therapy Presented New Preclinical Data in an Oral Presentation at ASGCT 2024 Annual Meeting Highlighting Superior Tumor Inhibition of its Immunoswitch Armored HPV-TCR T Cell Therapy (SCG142) against a Broad Range of HPV-associated Cancers
SINGAPORE, May 13, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, announced first preclinical data of its novel human papillomavirus (HPV)-specific T cell receptor-...
2024-05-13 10:00
2259
Saving 70% of water - New Irrigation System Revolutionizes Farming in Tropical Regions
TAIPEI, May 13, 2024 /PRNewswire/ -- After decades of dormancy, irrigation technology has finally received a sustainable upgrade. According to Grand View Research, the global irrigation automation market size to be valued atUSD 8.96 billion by 2027 and is expected to grow at a compound annual gr...
2024-05-13 09:00
1300
Caliway to Present the Latest Clinical Advancements at 2024 BIO International Convention
NEW TAIPEI CITY, May 11, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) is pleased to announce its participation to share the latest clinical advancements at the upcoming 2024 BIO International Convention onWednesday, June 5th, at 11:45 a.m. PDT. The presentation will take place in Com...
2024-05-11 15:14
2840
Single-Cell Multi-Omics Analysis of IASO Bio's Equecabtagene Autoleucel in the Treatment of Autoimmune Diseases of the Central Nervous System Published in Science Immunology
SHANGHAI, NANJING, China, and SAN JOSE, Calif., May 10, 2024 /PRNewswire/ -- On May 10, 2024, the impactful international academic journal, Science Immunology, a sub-journal ofScience, published a research paper titled "Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central...
2024-05-11 10:16
3791
Zepp Health Corporation Announces Receipt of NYSE Non-compliance Letter Regarding ADS Trading Price
MILPITAS, Calif., May 10, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that it has received a letter from the New York Stock Exchange (the "NYSE") datedApril 30, 2024, notifying Zepp ...
2024-05-11 05:00
4765
Week's Top Stories
Most Reposted
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
[Picked up by 321 media titles]
2024-05-08 14:37
OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology
[Picked up by 312 media titles]
2024-05-08 08:00IN2MF in Kuala Lumpur Presented by Bank Indonesia
[Picked up by 299 media titles]
2024-05-08 16:44
Thousands set to gather in Singapore for Rotary's international convention, the Garden City's largest association event post-pandemic
[Picked up by 289 media titles]
2024-05-09 11:00
i2Cool Attracts Close to HKD100 Million in Series A Financing to Propel the Development of Green and Energy-Efficient Radiant Cooling Solutions
[Picked up by 283 media titles]
2024-05-09 10:50
Most Read
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
2024-05-08 14:37
12457
IN2MF in Kuala Lumpur Presented by Bank Indonesia
2024-05-08 16:44
12077
